BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38060003)

  • 1. Willingness to participate in combination screening for lung cancer, chronic obstructive pulmonary disease and cardiovascular disease in four European countries.
    Behr C; Koffijberg H; IJzerman M; Kauczor HU; Revel MP; Silva M; von Stackelberg O; van Til J; Vliegenthart R
    Eur Radiol; 2023 Dec; ():. PubMed ID: 38060003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can we increase efficiency of CT lung cancer screening by combining with CVD and COPD screening? Results of an early economic evaluation.
    Behr CM; Koffijberg H; Degeling K; Vliegenthart R; IJzerman MJ
    Eur Radiol; 2022 May; 32(5):3067-3075. PubMed ID: 34973103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality and Morbidity Effects of Long-Term Exposure to Low-Level PM
    Brunekreef B; Strak M; Chen J; Andersen ZJ; Atkinson R; Bauwelinck M; Bellander T; Boutron MC; Brandt J; Carey I; Cesaroni G; Forastiere F; Fecht D; Gulliver J; Hertel O; Hoffmann B; de Hoogh K; Houthuijs D; Hvidtfeldt U; Janssen N; Jorgensen J; Katsouyanni K; Ketzel M; Klompmaker J; Hjertager Krog N; Liu S; Ljungman P; Mehta A; Nagel G; Oftedal B; Pershagen G; Peters A; Raaschou-Nielsen O; Renzi M; Rodopoulou S; Samoli E; Schwarze P; Sigsgaard T; Stafoggia M; Vienneau D; Weinmayr G; Wolf K; Hoek G
    Res Rep Health Eff Inst; 2021 Sep; 2021(208):1-127. PubMed ID: 36106702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population-Based Screening Using Low-Dose Chest Computed Tomography: A Systematic Review of Health Economic Evaluations.
    Behr CM; Oude Wolcherink MJ; IJzerman MJ; Vliegenthart R; Koffijberg H
    Pharmacoeconomics; 2023 Apr; 41(4):395-411. PubMed ID: 36670332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current and Former Smokers: Who Wants To Be Screened?
    Couraud S; Greillier L; Brignoli-Guibaudet L; Lhomel C; Viguier J; Morère JF; Eisinger F; Cortot AB
    Clin Lung Cancer; 2018 Nov; 19(6):493-501. PubMed ID: 30107977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preferences for colorectal cancer screening techniques and intention to attend: a multi-criteria decision analysis.
    Hummel JM; Steuten LG; Groothuis-Oudshoorn CJ; Mulder N; Ijzerman MJ
    Appl Health Econ Health Policy; 2013 Oct; 11(5):499-507. PubMed ID: 23979875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with low-dose CT lung cancer screening participation in a high burden state: Results from the 2017-2018 BRFSS.
    Sedani AE; Ford LA; James SA; Beebe LA
    J Cancer Policy; 2021 Jun; 28():100284. PubMed ID: 35559913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beliefs and Intentions to Undergo Lung Cancer Screening among Korean Males.
    Bui NC; Lee YY; Suh M; Park B; Cho H; Kim Y; Choi KS
    Cancer Res Treat; 2018 Oct; 50(4):1096-1105. PubMed ID: 29141395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary Drivers of Willingness to Continue to Participate in Community-Based Health Screening for Chronic Diseases.
    Chien SY; Chuang MC; Chen IP; Yu PH
    Int J Environ Res Public Health; 2019 May; 16(9):. PubMed ID: 31083535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic obstructive pulmonary disease prevalence and prediction in a high-risk lung cancer screening population.
    Goffin JR; Pond GR; Puksa S; Tremblay A; Johnston M; Goss G; Nicholas G; Martel S; Bhatia R; Liu G; Schmidt H; Atkar-Khattra S; McWilliams A; Tsao MS; Tammemagi MC; Lam S
    BMC Pulm Med; 2020 Nov; 20(1):300. PubMed ID: 33198781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Why People Do Not Attend Health Screenings: Factors That Influence Willingness to Participate in Health Screenings for Chronic Diseases.
    Chien SY; Chuang MC; Chen IP
    Int J Environ Res Public Health; 2020 May; 17(10):. PubMed ID: 32429532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Likely uptake of a future a lung cancer screening programme in Hodgkin lymphoma survivors: a questionnaire study.
    Broadbent R; Armitage CJ; Crosbie P; Radford J; Linton K
    BMC Pulm Med; 2022 Apr; 22(1):165. PubMed ID: 35484621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Willingness to participate and take risks in HIV cure research: survey results from 400 people living with HIV in the US.
    Dubé K; Evans D; Sylla L; Taylor J; Weiner BJ; Skinner A; Thirumurthy H; Tucker JD; Rennie S; Greene SB
    J Virus Erad; 2017 Jan; 3(1):40-50.e21. PubMed ID: 28275457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of Willingness to Undergo Lung Cancer Screening among High-Risk Current and Ex-smokers in Sabah, Malaysia: A Cross-Sectional Pilot Study.
    Nyanti LE; Chua CZ; Loo HC; Khor CZ; Toh ESY; Gill RS; Chan ET; Tan KY; Rosli T; Rahim MAA; Ibrahim A; Huan NC; Ramarmuty HYD; Kannan KKS
    Tuberc Respir Dis (Seoul); 2023 Oct; 86(4):284-293. PubMed ID: 37643812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Personalizing annual lung cancer screening for patients with chronic obstructive pulmonary disease: A decision analysis.
    Lowry KP; Gazelle GS; Gilmore ME; Johanson C; Munshi V; Choi SE; Tramontano AC; Kong CY; McMahon PM
    Cancer; 2015 May; 121(10):1556-62. PubMed ID: 25652107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lung Cancer Screening: Characteristics of Nonparticipants and Potential Screening Barriers.
    Raju S; Khawaja A; Han X; Wang X; Mazzone PJ
    Clin Lung Cancer; 2020 Sep; 21(5):e329-e336. PubMed ID: 32371161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overwhelming support among urban Irish COPD patients for lung cancer screening by low-dose CT scan.
    Pallin M; Walsh S; O'Driscoll MF; Murray C; Cahalane A; Brown L; Carter M; Mitchell P; McDonnell TJ; Butler MW
    Lung; 2012 Dec; 190(6):621-8. PubMed ID: 23064487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accelerating integration of tobacco use treatment in the context of lung cancer screening: Relevance and application of implementation science to achieving policy and practice.
    Shelley D; Wang VH; Taylor K; Williams R; Toll B; Rojewski A; Foley KL; Rigotti N; Ostroff JS
    Transl Behav Med; 2022 Nov; 12(11):1076-1083. PubMed ID: 36227937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Barriers to uptake among high-risk individuals declining participation in lung cancer screening: a mixed methods analysis of the UK Lung Cancer Screening (UKLS) trial.
    Ali N; Lifford KJ; Carter B; McRonald F; Yadegarfar G; Baldwin DR; Weller D; Hansell DM; Duffy SW; Field JK; Brain K
    BMJ Open; 2015 Jul; 5(7):e008254. PubMed ID: 26173719
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.